Lv2
140 积分 2022-05-19 加入
Peptide‐drug conjugate designated for targeted delivery to HER2‐expressing cancer cells
1天前
已完结
Design and biological activity of epidermal growth factor receptor-targeted peptide doxorubicin conjugate
1天前
已完结
Recent Progress in the Development of Peptide-Drug Conjugates (PDCs) for Cancer Therapy
1天前
已完结
Exploiting novel placental homing peptides for targeted drug delivery in breast Cancer
2天前
已完结
Recent Progress in the Development of Peptide-Drug Conjugates (PDCs) for Cancer Therapy
2天前
已完结
Recent Advances in Targeted Cancer Therapy: Are PDCs the Next Generation of ADCs?
3天前
已完结
Peptide-drug conjugates: A new paradigm for targeted cancer therapy
3天前
已完结
Abstract P4-01-21: Phase 2 Study of the CDK4/6 Inhibitor FCN-437c in Combination With Fulvestrant or Letrozole and Goserelin in Patients With HR+, HER2– Advanced Breast Cancer
8天前
已关闭
A patent review of UNC-51-like kinase 1/2 inhibitors (2019-present)
1个月前
已完结
Growth Hormone Deficiency in Adulthood and the Effects of Growth Hormone Replacement: A Review
2个月前
已完结
皖公网安备34019202002308
